Cargando…

Pneumococcal Vaccination Rates in VHA Patients With Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is an inflammatory condition of the digestive tract not caused by infectious agents. Symptoms of IBD, such as diarrhea and pain, diminish one's quality of life. Underlying immune dysregulation may put IBD patients at risk for severe infectious disease making pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Case, David J., Copeland, Laurel A., Stock, Eileen M., Herrera, Henry R., Pfanner, Timothy P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602733/ https://www.ncbi.nlm.nih.gov/pubmed/25674731 http://dx.doi.org/10.1097/MD.0000000000000417

Ejemplares similares

Preventative care for patients with inflammatory bowel disease in the Veterans Health Administration
por: Pandey, Nivedita, et al.
Publicado: (2016)

Insufficient vaccination and inadequate immunization rates among Korean patients with inflammatory bowel diseases
por: Ryu, Han Hee, et al.
Publicado: (2021)

Heart rate variability and inflammatory bowel disease in humans: A systematic review and meta-analysis
por: Kim, Kyu-Nam, et al.
Publicado: (2020)

Evaluation of Factors Associated With Response to Hepatitis B Vaccination in Patients With Inflammatory Bowel Disease
por: Cekic, Cem, et al.
Publicado: (2015)

Thalidomide for inflammatory bowel disease: Systematic review
por: Bramuzzo, Matteo, et al.
Publicado: (2016)

Pulmonary dysfunction in 114 patients with inflammatory bowel disease
por: Zhao, Yujie, et al.
Publicado: (2017)

Inflammatory bowel disease and associated cardiovascular disease outcomes: A systematic review
por: Jaiswal, Vikash, et al.
Publicado: (2023)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement
por: Ianiro, Gianluca, et al.
Publicado: (2014)

Physical activity and quality of life of patients with inflammatory bowel disease
por: Kim, Bun, et al.
Publicado: (2021)

What are the risk factors for extraintestinal manifestations in inflammatory bowel diseases?
por: Yeo, Min-Kyung, et al.
Publicado: (2023)

Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2022)

Lower vitamin D levels are associated with the pathogenesis of inflammatory bowel diseases
por: Topalova-Dimitrova, Antonia, et al.
Publicado: (2023)

Diagnosis of Iron Deficiency in Inflammatory Bowel Disease by Transferrin Receptor-Ferritin Index
por: Abitbol, Vered, et al.
Publicado: (2015)

DNA Methylation Profile of Genes Involved in Inflammation and Autoimmunity in Inflammatory Bowel Disease
por: Karatzas, Pantelis S., et al.
Publicado: (2014)

Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review
por: Nielsen, Ole Haagen, et al.
Publicado: (2015)

Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease
por: Martinez-Fierro, Margarita L., et al.
Publicado: (2019)

Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients
por: Juliao-Baños, Fabian, et al.
Publicado: (2021)

Inflammatory Bowel Disease Increases the Risk of Peripheral Arterial Disease: A Nationwide Cohort Study
por: Lin, Te-Yu, et al.
Publicado: (2015)

The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease
por: Lee, Hye Won, et al.
Publicado: (2016)

Therapeutic strategies of thromboembolic events in patients with inflammatory bowel diseases: Two case reports
por: Zhu, Lei, et al.
Publicado: (2019)

Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life
por: Ozer, Muhammet, et al.
Publicado: (2020)

Efficacy and Safety of Antiintegrin Antibody for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Lin, Lianjie, et al.
Publicado: (2015)

Clostridium difficile infection in hospitalized patients with inflammatory bowel disease: Prevalence, risk factors, and prognosis
por: Maharshak, Nitsan, et al.
Publicado: (2018)

A rare complication of people with inflammatory bowel disease after ileostomy: A case report
por: Jiang, Hong, et al.
Publicado: (2023)

Accuracy of the highly sensitive C-reactive protein/albumin ratio to determine disease activity in inflammatory bowel disease
por: Liu, Ailing, et al.
Publicado: (2021)

Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study
por: Fangbin, Zhang, et al.
Publicado: (2016)

Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: A meta-analysis
por: Yao, Liwei, et al.
Publicado: (2017)

Enterohepatic Helicobacter Species as a Potential Causative Factor in Inflammatory Bowel Disease: A Meta-Analysis
por: Yu, Qiao, et al.
Publicado: (2015)

Association between PTGER4 polymorphisms and inflammatory bowel disease risk in Caucasian: A meta-analysis
por: Wu, Peng-Bo, et al.
Publicado: (2020)

The features and clinical outcomes of inflammatory bowel disease associated with autoimmune pancreatitis: A greater awareness is needed
por: Conti Bellocchi, Maria Cristina, et al.
Publicado: (2022)

Anxiety and depression in patients with inactive inflammatory bowel disease: The role of fatigue and health-related quality of life
por: Stroie, Tudor, et al.
Publicado: (2023)

The association of the MTHFR C677T polymorphism with inflammatory bowel diseases in the Israeli Jewish population: An example of genetic heterogeneity
por: Karban, Amir, et al.
Publicado: (2016)

Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study
por: Schüle, Solvey, et al.
Publicado: (2017)

Health-related quality of life and costs of switching originator infliximab to biosimilar one in treatment of inflammatory bowel disease
por: Huoponen, Saara, et al.
Publicado: (2020)

A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UK: The REVIVE study
por: Cummings, Fraser, et al.
Publicado: (2019)

Inflammatory bowel disease can reduce ovarian reserve function in women: A systematic review and meta-analysis
por: Guo, Lin, et al.
Publicado: (2023)

Aberrant expression of miR-21 in patients with inflammatory bowel disease: A protocol for systematic review and meta analysis
por: Yan, Huimin, et al.
Publicado: (2020)

Association of Glutathione S-Transferase M1 null genotype with inflammatory bowel diseases: A systematic review and meta-analysis
por: Zhou, Yu-Jie, et al.
Publicado: (2019)

Cytomegalovirus enterocolitis with subsequent diagnosis of coexisting new-onset inflammatory bowel disease: Two case reports and review of the literature
por: Luangsirithanya, Panupong, et al.
Publicado: (2021)

Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease: A pilot study
por: Ye, Lei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pl5di7dq0j04n3tk6iorsoppjj